Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00614042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/1b Study of TRU-016 in Patients With Previously Treated Chronic Lymphocytic Leukemia or Select Subtypes of Non-Hodgkin's Lymphoma
Study identification
- NCT ID
- NCT00614042
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Aptevo Therapeutics
- Industry
- Enrollment
- 96 participants
Conditions and interventions
Interventions
- TRU-016 (anti-CD37 protein therapeutic) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2007
- Primary completion
- Nov 30, 2011
- Completion
- Feb 29, 2012
- Last update posted
- Jun 27, 2017
2008 – 2012
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| For additional information regarding sites for this trial call 919-319-9374 | Birmingham | Alabama | 35294 | — |
| For additional information regarding sites for this trial call 919-319-9374 | Augusta | Georgia | 30912 | — |
| For additional information regarding sites for this trial call 919-319-9374 | Boston | Massachusetts | 02111 | — |
| For additional information regarding sites for this trial call 919-319-9374 | Las Vegas | Nevada | 89135 | — |
| For additional information regarding sites for this trial call 919-319-9374 | Durham | North Carolina | 27710 | — |
| For additional information regarding sites for this trial call 919-319-9374 | Portland | Oregon | 97239 | — |
| For additional information regarding sites for this trial call 919-319-9374 | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00614042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2017 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00614042 live on ClinicalTrials.gov.